Determinants of survival after intraarterial infusion of 5-fluorouracil for liver metastases from colorectal cancer: A multivariate analysis
✍ Scribed by Dr. Henrik Ekberg; Karl-Göran Tranberg; Christer Lundstedt; Gunnar Hanff; Jonas Ranstam; Bengt Jeppsson; Stig Bengmark
- Publisher
- John Wiley and Sons
- Year
- 1986
- Tongue
- English
- Weight
- 746 KB
- Volume
- 31
- Category
- Article
- ISSN
- 0022-4790
No coin nor oath required. For personal study only.
✦ Synopsis
A consecutive series of 73 patients treated with intraarterial infusion of 5fluorouracil (5-FU) for liver metastases from colorectal primary was studied retrospectively using multivariate analysis in order to find determinants of survival. Nontreatment factors had a great impact on variation in survival with liver tumor volume and metastases to lymph glands in the liver hilum as major prognostic determinants. in addition, survival from onset of treatment varied with the interval between the primary operation and the diagnosis of liver metastases. Treatment with intraarterial 5-FU was more effective when administered at long-term (3 months every 6 months) than at short-term (5 days every 6 weeks). Single temporary dearterialization, used as an adjunct to infusion of 5-FU, had a negative impact on length of survival and was followed by a high frequency of complications. The occurrence of hepatic arterial thrombosis was associated with comparatively good prognosis.
📜 SIMILAR VOLUMES
Background. Regional therapy for colorectal liver metastases aimed at prolonging survival has not been tested fully in a randomized trial with untreated control subjects. This study explored the efficacy of temporary hepatic artery occlusion followed by intraportal infusion of 5-fluorouracil[5-FU) a
We studied the effect of combined chemo-immunotherapy, 5-FU followed by thymosin al (Toll) and interleukin-2 (IL-2) at low doses, on liver metastases from colorectal cancer, induced by splenic injection of DHD/KIZ cells (I ,2-dimethylhydrazineinduced colon adenocarcinoma) in syngeneic BDIX rats. The